正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

BPC-157 is the peptide almost everyone starts with. Here is my full masterclass on it. 00:00 Intro and why BPC-157 01:44 What BPC-157 actually is 03:58 How it works in the body 07:32 Healing, inflammation and the brain 12:18 Who it is for and who skips it 14:20 Contraindications... show more

Hunter Williams

8,664 subscribers

27,198 次观看 • 1 个月前 •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

I would take KPV over BPC-157 and TB-500 any day. Here's my full masterclass on it. 03:24 What KPV actually is and where it comes from 05:34 NF-kappa B: the master inflammation switch KPV shuts off 07:54 Why KPV targets inflamed tissue and leaves healthy tissue alone 11:48 Who benefits: IBD, Crohn's, ulcerative colitis 12:56 Breaking the BPC and TB-500 plateau 14:02 Autoimmune, skin conditions and MCAS 15:42 Dosing Tier 1: 250mcg 16:54 Dosing Tier 2: 500mcg for active healing 17:16 Dosing Tier 3: 1mg+ for severe inflammation 26:56 Sequencing: calm the fire before you rebuild 31:36 Stacking with BPC-157, TB-500, LL-37 and GLPs 40:34 Long COVID and MCAS 43:20 KPV is the peptide that calms the room

I would take KPV over BPC-157 and TB-500 any day. Here's my full masterclass on it. 03:24 What KPV actually is and where it comes from 05:34 NF-kappa B: the master inflammation switch KPV shuts off 07:54 Why KPV targets inflamed tissue and leaves healthy tissue alone 11:48 Who benefits: IBD, Crohn's, ulcerative colitis 12:56 Breaking the BPC and TB-500 plateau 14:02 Autoimmune, skin conditions and MCAS 15:42 Dosing Tier 1: 250mcg 16:54 Dosing Tier 2: 500mcg for active healing 17:16 Dosing Tier 3: 1mg+ for severe inflammation 26:56 Sequencing: calm the fire before you rebuild 31:36 Stacking with BPC-157, TB-500, LL-37 and GLPs 40:34 Long COVID and MCAS 43:20 KPV is the peptide that calms the room

Hunter Williams

30,680 次观看 • 2 个月前

i wouldn't get used to polished MOTS but i figured what better way to announce a Superpower partnership than to bring in some cameras and microphones and have a super serious debate on peptides and looksmaxxing with Max Marchione 00:00 - Intro to Peps (Peptides) 2:25 - Addressing potential allegations 3:55 - Peptide messaging 7:20 - BPC-157 12:05 - BPC-157 Cancer risk? 17:55 - The changing definition of medicine 19:05 - How is the peptide craze different to the steroid/SARM craze? 22:45 - FDA approval 26:00 - Looksmaxxing intro 29:00 - Mewing 30:25 - Bone Smashing and Turkish Leg Lengthening 32:55 - Mouth Taping 34:30 - Looksmaxxing with peptides and looksmaxxing as a trend 39:00 - What the hell is on our table?

i wouldn't get used to polished MOTS but i figured what better way to announce a Superpower partnership than to bring in some cameras and microphones and have a super serious debate on peptides and looksmaxxing with Max Marchione 00:00 - Intro to Peps (Peptides) 2:25 - Addressing potential allegations 3:55 - Peptide messaging 7:20 - BPC-157 12:05 - BPC-157 Cancer risk? 17:55 - The changing definition of medicine 19:05 - How is the peptide craze different to the steroid/SARM craze? 22:45 - FDA approval 26:00 - Looksmaxxing intro 29:00 - Mewing 30:25 - Bone Smashing and Turkish Leg Lengthening 32:55 - Mouth Taping 34:30 - Looksmaxxing with peptides and looksmaxxing as a trend 39:00 - What the hell is on our table?

atlas

33,345 次观看 • 6 个月前

MOTS-c is encoded in your mitochondrial DNA. Not your nuclear DNA. It was only discovered in 2015. Most people using it still do not understand what it actually does. Here's my full masterclass on it. Free. 00:00 Intro and why MOTS-c is misunderstood 02:48 What MOTS-c actually is 04:12 Discovery and the mitochondrial genome 06:28 How MOTS-c works: AMPK and dual action 10:40 MOTS-c vs SS-31 and humanin 11:58 Who should use it 14:18 Who should skip it 17:30 Dosing tiers and timeline 24:00 Cycling MOTS-c 27:18 Pairing with SS-31 and humanin 31:00 Reconstitution and injection 33:36 Tracking and stacking 35:48 Troubleshooting and side effects 38:10 FAQ 41:12 Where the science is heading 42:42 Final takeaways

MOTS-c is encoded in your mitochondrial DNA. Not your nuclear DNA. It was only discovered in 2015. Most people using it still do not understand what it actually does. Here's my full masterclass on it. Free. 00:00 Intro and why MOTS-c is misunderstood 02:48 What MOTS-c actually is 04:12 Discovery and the mitochondrial genome 06:28 How MOTS-c works: AMPK and dual action 10:40 MOTS-c vs SS-31 and humanin 11:58 Who should use it 14:18 Who should skip it 17:30 Dosing tiers and timeline 24:00 Cycling MOTS-c 27:18 Pairing with SS-31 and humanin 31:00 Reconstitution and injection 33:36 Tracking and stacking 35:48 Troubleshooting and side effects 38:10 FAQ 41:12 Where the science is heading 42:42 Final takeaways

Hunter Williams

33,825 次观看 • 1 个月前

BPC-157 and TB-500 are two of the most talked-about peptides in fitness, bodybuilding, and biohacking. Together they’re often called the “Wolverine Stack” — a peptide combination rumored to dramatically accelerate healing of tendons, ligaments, muscles, and injuries. But do BPC-157 and TB-500 actually work in humans, or is the Wolverine Stack just another example of internet bro-science? In this evidence-based deep dive, Dr. Alex Tatem (board-certified urologist and men’s health specialist) breaks down the real science behind BPC-157 and TB-500 — including their biochemical mechanisms, animal research, potential healing effects, safety concerns, and why pharmaceutical companies have never brought these peptides through full FDA clinical trials. We explore the nitric oxide signaling, angiogenesis, VEGF pathways, actin regulation, and tissue repair biology behind these compounds and explain why rodent studies look promising — but why human clinical evidence is still extremely limited. You’ll also learn about: • What BPC-157 (Body Protection Compound-157) actually is • TB-500 vs Thymosin Beta-4 explained • The origin of the Wolverine Stack peptide protocol • Peptides for tendon healing and ligament injuries • BPC-157 for gut healing and musculoskeletal repair • TB-500 and actin-mediated tissue regeneration • Why most peptide research comes from one Croatian research group • The patent law problem preventing pharmaceutical development • Real risks of grey-market peptide contamination • Why WADA bans BPC-157 and TB-500 in competitive athletes • Theoretical cancer risks related to angiogenesis • What the current scientific literature actually shows If you've ever searched: “Does BPC-157 work?” “What is TB-500?” “Peptides for healing injuries” “BPC-157 tendon repair” “Wolverine Stack peptides explained” — this video breaks down the science. The peptides may be promising. But promise and proof are not the same thing. Drop a comment below: Have you ever used BPC-157, TB-500, or other peptides? What was your experience? 👍 Like the video if you want more evidence-based breakdowns of supplements, PEDs, and peptides. Subscribe for deep dives on testosterone, steroids, peptides, supplements, and men’s health science.

BPC-157 and TB-500 are two of the most talked-about peptides in fitness, bodybuilding, and biohacking. Together they’re often called the “Wolverine Stack” — a peptide combination rumored to dramatically accelerate healing of tendons, ligaments, muscles, and injuries. But do BPC-157 and TB-500 actually work in humans, or is the Wolverine Stack just another example of internet bro-science? In this evidence-based deep dive, Dr. Alex Tatem (board-certified urologist and men’s health specialist) breaks down the real science behind BPC-157 and TB-500 — including their biochemical mechanisms, animal research, potential healing effects, safety concerns, and why pharmaceutical companies have never brought these peptides through full FDA clinical trials. We explore the nitric oxide signaling, angiogenesis, VEGF pathways, actin regulation, and tissue repair biology behind these compounds and explain why rodent studies look promising — but why human clinical evidence is still extremely limited. You’ll also learn about: • What BPC-157 (Body Protection Compound-157) actually is • TB-500 vs Thymosin Beta-4 explained • The origin of the Wolverine Stack peptide protocol • Peptides for tendon healing and ligament injuries • BPC-157 for gut healing and musculoskeletal repair • TB-500 and actin-mediated tissue regeneration • Why most peptide research comes from one Croatian research group • The patent law problem preventing pharmaceutical development • Real risks of grey-market peptide contamination • Why WADA bans BPC-157 and TB-500 in competitive athletes • Theoretical cancer risks related to angiogenesis • What the current scientific literature actually shows If you've ever searched: “Does BPC-157 work?” “What is TB-500?” “Peptides for healing injuries” “BPC-157 tendon repair” “Wolverine Stack peptides explained” — this video breaks down the science. The peptides may be promising. But promise and proof are not the same thing. Drop a comment below: Have you ever used BPC-157, TB-500, or other peptides? What was your experience? 👍 Like the video if you want more evidence-based breakdowns of supplements, PEDs, and peptides. Subscribe for deep dives on testosterone, steroids, peptides, supplements, and men’s health science.

Dr. Alex Tatem

21,218 次观看 • 5 个月前

THE GREAT PEPTIDE DEBATE: FULL DISCUSSION Peptide bear Martin Shkreli squared off against peptide bull Max Marchione today in a back and forth on retatrutide, BPC-157, randomized controlled trials, the FDA, the pharmaceutical industry, and more. 00:00 Opening arguments 06:08 Martin on the downsides of retatrutide 10:24 Back and forth on BPC-157 14:41 Randomized controlled trials — issues and benefits 19:19 Max on the potential of Thymosin Alpha-1 23:21 Martin on why peptides should be controlled substances 26:07 The FDA's strengths and weaknesses 29:05 Closing arguments

THE GREAT PEPTIDE DEBATE: FULL DISCUSSION Peptide bear Martin Shkreli squared off against peptide bull Max Marchione today in a back and forth on retatrutide, BPC-157, randomized controlled trials, the FDA, the pharmaceutical industry, and more. 00:00 Opening arguments 06:08 Martin on the downsides of retatrutide 10:24 Back and forth on BPC-157 14:41 Randomized controlled trials — issues and benefits 19:19 Max on the potential of Thymosin Alpha-1 23:21 Martin on why peptides should be controlled substances 26:07 The FDA's strengths and weaknesses 29:05 Closing arguments

TBPN

174,214 次观看 • 4 个月前

Where BPC-157 peptide comes from and how it affects the body: - Croatian research group in the '90s isolated BPC-157 from a much larger 40,000-unit peptide naturally found in the gut - it is 15 amino acids long and is not something the body produces on its own. - Researchers theorized the stomach contained a cytoprotective compound after Pavlov's gastric juice experiments showed healing effects on GI tissue. - BPC-157 accelerates repair by upregulating VEGF signaling (new blood vessel formation), boosting nitric oxide synthesis, and increasing growth hormone receptors on tendons. - Corticosteroids normally halt wound healing - BPC-157 administered alongside them maintained or even improved healing outcomes in animal models. - In mouse models, BPC-157 reduced intoxication, blunted alcohol withdrawal symptoms, and appears to modulate dopaminergic signaling - effects that get far less attention than its musculoskeletal uses. Abud Bakri MD on Andrew D. Huberman, Ph.D.

Where BPC-157 peptide comes from and how it affects the body: - Croatian research group in the '90s isolated BPC-157 from a much larger 40,000-unit peptide naturally found in the gut - it is 15 amino acids long and is not something the body produces on its own. - Researchers theorized the stomach contained a cytoprotective compound after Pavlov's gastric juice experiments showed healing effects on GI tissue. - BPC-157 accelerates repair by upregulating VEGF signaling (new blood vessel formation), boosting nitric oxide synthesis, and increasing growth hormone receptors on tendons. - Corticosteroids normally halt wound healing - BPC-157 administered alongside them maintained or even improved healing outcomes in animal models. - In mouse models, BPC-157 reduced intoxication, blunted alcohol withdrawal symptoms, and appears to modulate dopaminergic signaling - effects that get far less attention than its musculoskeletal uses. Abud Bakri MD on Andrew D. Huberman, Ph.D.

Huberman Lab Clips

97,189 次观看 • 2 个月前

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

Dr. Alex Tatem

76,818 次观看 • 3 个月前

$HIMS 🚨 THE FDA PEPTIDES VOTE IS DAYS AWAY Peptides insider Jesse Morse, M.D. expects approval We discuss the FDA briefing document recommending *against* the 7 peptides, what the odds of approval are for each of the peptides under review (including BPC-157) and why U.S.-made API could be a major advantage for $HIMS 01:37 - FDA briefing document 03:24 - Getting peptides back in front of the FDA 08:58 - Prescribing peptides back in 2017 12:42 - Peptides safety data 16:08 - BPC-157 deep-dive and odds for approval 22:56 - TB-500 deep-dive 26:15 - Approval odds for the other 5 peptides 31:02 - Peptide efficacy data 34:40 - FDA politics and final decisions 40:30 - Peptides market size 42:48 - Training the doctors 47:20 - Shipping hurdles and gray-market risk 53:25 - Why peptides could reshape healthcare Not financial, legal, or medical advice

$HIMS 🚨 THE FDA PEPTIDES VOTE IS DAYS AWAY Peptides insider Jesse Morse, M.D. expects approval We discuss the FDA briefing document recommending against the 7 peptides, what the odds of approval are for each of the peptides under review (including BPC-157) and why U.S.-made API could be a major advantage for $HIMS 01:37 - FDA briefing document 03:24 - Getting peptides back in front of the FDA 08:58 - Prescribing peptides back in 2017 12:42 - Peptides safety data 16:08 - BPC-157 deep-dive and odds for approval 22:56 - TB-500 deep-dive 26:15 - Approval odds for the other 5 peptides 31:02 - Peptide efficacy data 34:40 - FDA politics and final decisions 40:30 - Peptides market size 42:48 - Training the doctors 47:20 - Shipping hurdles and gray-market risk 53:25 - Why peptides could reshape healthcare Not financial, legal, or medical advice

Hims House

184,812 次观看 • 1 个月前

BPC-157 is not your typical pharmaceutical compound that forces a single outcome, but rather it restores conditions that allow the body to do what it already knows how to do. Gary Brecka and his team have put thousands of people on BPC-157. None of them had any adverse effects.

BPC-157 is not your typical pharmaceutical compound that forces a single outcome, but rather it restores conditions that allow the body to do what it already knows how to do. Gary Brecka and his team have put thousands of people on BPC-157. None of them had any adverse effects.

Real Peptides

165,980 次观看 • 3 个月前

Everything worth knowing about the most underrated mitochondrial peptide in the space. My SS-31 masterclass. 00:00 Intro 02:45 The FDA approval story and what it means for peptides 03:18 Why SS-31 is different from every other peptide 06:02 Nearly every chronic disease of aging involves this 10:46 How SS-31 actually works 11:12 Why no receptor means no desensitization 13:36 Who SS-31 is for 15:34 The three tier dosing ladder 24:24 Why SS-31 must come before MOTS-c 29:18 How to stack it correctly 32:26 Troubleshooting when you feel nothing 36:54 Long COVID, TRT, athletic performance use cases

Everything worth knowing about the most underrated mitochondrial peptide in the space. My SS-31 masterclass. 00:00 Intro 02:45 The FDA approval story and what it means for peptides 03:18 Why SS-31 is different from every other peptide 06:02 Nearly every chronic disease of aging involves this 10:46 How SS-31 actually works 11:12 Why no receptor means no desensitization 13:36 Who SS-31 is for 15:34 The three tier dosing ladder 24:24 Why SS-31 must come before MOTS-c 29:18 How to stack it correctly 32:26 Troubleshooting when you feel nothing 36:54 Long COVID, TRT, athletic performance use cases

Hunter Williams

20,655 次观看 • 2 个月前

Want to heal faster, reduce inflammation, and rebuild stronger? Meet BPC 157—one of the most powerful peptides for recovery & gut health. This peptide is derived from gastric juice and works by: ✅ Increasing growth factors at injury sites (helping joints, tendons, and muscles heal faster) ✅ Sealing & healing the gut (excellent for digestion & gut permeability) ✅ Reducing chronic inflammation at the cellular level Whether you’re recovering from injury, surgery, or gut issues, BPC 157 is something to discuss with your functional medicine doctor. The body is designed to heal—let’s give it the right tools. Have you ever used peptides? Let’s talk about it in the comments!

Want to heal faster, reduce inflammation, and rebuild stronger? Meet BPC 157—one of the most powerful peptides for recovery & gut health. This peptide is derived from gastric juice and works by: ✅ Increasing growth factors at injury sites (helping joints, tendons, and muscles heal faster) ✅ Sealing & healing the gut (excellent for digestion & gut permeability) ✅ Reducing chronic inflammation at the cellular level Whether you’re recovering from injury, surgery, or gut issues, BPC 157 is something to discuss with your functional medicine doctor. The body is designed to heal—let’s give it the right tools. Have you ever used peptides? Let’s talk about it in the comments!

Gary Brecka

70,278 次观看 • 1 年前

Ahhh, the dichotomy of San Francisco. Where the fentanyl zombies now mingle with the peptide-injecting biohackers and share the same city-sponsored drug testing centers. Our full episode on SF's peptide scene is here with jasmine sun joining Kylie Robison and me. You know what's like putting your finances on the Wolverine Stack? Well, that would be Brex And if you have the things that's actually better than grey market peptides, hit up E1 Ventures 🇺🇸 for your investing needs. Timestamps 00:00:00 Intro 00:04:58 The Gray Market Peptide Boom 00:10:50 Cancer Risks and Biohacking Safety 00:13:36 Inside San Francisco’s Peptide Rave 00:19:43 DIY Ozempic and Kitchen Chemistry 00:23:05 RFK Jr. vs The FDA 00:26:43 Is Biohacking a Chinese Psyop? 00:40:44 Leaving Tech for New Media 00:46:29 The Media vs Tech Disconnect 00:53:58 Defense Tech and American Dynamism 01:00:37 Spy Mania and Visa Nightmares 01:08:20 Why AGI Timelines Are Dead

Ahhh, the dichotomy of San Francisco. Where the fentanyl zombies now mingle with the peptide-injecting biohackers and share the same city-sponsored drug testing centers. Our full episode on SF's peptide scene is here with jasmine sun joining Kylie Robison and me. You know what's like putting your finances on the Wolverine Stack? Well, that would be Brex And if you have the things that's actually better than grey market peptides, hit up E1 Ventures 🇺🇸 for your investing needs. Timestamps 00:00:00 Intro 00:04:58 The Gray Market Peptide Boom 00:10:50 Cancer Risks and Biohacking Safety 00:13:36 Inside San Francisco’s Peptide Rave 00:19:43 DIY Ozempic and Kitchen Chemistry 00:23:05 RFK Jr. vs The FDA 00:26:43 Is Biohacking a Chinese Psyop? 00:40:44 Leaving Tech for New Media 00:46:29 The Media vs Tech Disconnect 00:53:58 Defense Tech and American Dynamism 01:00:37 Spy Mania and Visa Nightmares 01:08:20 Why AGI Timelines Are Dead

Ashlee Vance

34,910 次观看 • 7 个月前

A full walkthrough of Conductor 00:00 What is Conductor? 01:50 UI 02:33 Adding projects 03:53 Setup and run scripts 05:25 Multiple agents and forking context 07:41 Running workspaces in the cloud 08:44 PRs, CI, and review workflow 11:14 Team workflows with branches and Linear

A full walkthrough of Conductor 00:00 What is Conductor? 01:50 UI 02:33 Adding projects 03:53 Setup and run scripts 05:25 Multiple agents and forking context 07:41 Running workspaces in the cloud 08:44 PRs, CI, and review workflow 11:14 Team workflows with branches and Linear

matt palmer

71,378 次观看 • 1 个月前

My discussion on how and why $STRC works with Jordan Walker. 00:00 Intro 00:51 - CJ Joins The Bitcoin Team At Strategy 02:12 - What CJ Actually Does Day To Day 05:25 - Behind The Scenes On Saylor’s Messaging And Strategy’s Content 08:34 - What CJ’s Learned Working Closely With Saylor 11:22 - Why Strategy Uses AI So Aggressively 14:21 - How The Bitcoin And Software Sides Fit Together Internally 17:07 - The Big Picture Strategy Model Explained (Jesse Meyers Graphic) 24:27 - What Stretch Is And Why It Exists 27:27 - How Stretch Helps Strategy Buy More Bitcoin 31:07 - How The Stretch Dividend Rate Gets Set And Adjusted 34:43 - Stretch Vs Stablecoin Yield 38:44 - Why Stretch Could Be Strategy’s “iPhone Moment” 41:41 - Who Can Copy This Model And Why Size Matters 44:46 - Using Stretch To Build Products Outside The US 46:28 - A UK Bank Product Backed By Stretch 47:48 - Why Stretch Is Attractive For Businesses Holding Cash 50:07 - Bitcoin For Corporations Is Now Stretch 52:53 - Where To Learn More And What’s Coming Next

My discussion on how and why $STRC works with Jordan Walker. 00:00 Intro 00:51 - CJ Joins The Bitcoin Team At Strategy 02:12 - What CJ Actually Does Day To Day 05:25 - Behind The Scenes On Saylor’s Messaging And Strategy’s Content 08:34 - What CJ’s Learned Working Closely With Saylor 11:22 - Why Strategy Uses AI So Aggressively 14:21 - How The Bitcoin And Software Sides Fit Together Internally 17:07 - The Big Picture Strategy Model Explained (Jesse Meyers Graphic) 24:27 - What Stretch Is And Why It Exists 27:27 - How Stretch Helps Strategy Buy More Bitcoin 31:07 - How The Stretch Dividend Rate Gets Set And Adjusted 34:43 - Stretch Vs Stablecoin Yield 38:44 - Why Stretch Could Be Strategy’s “iPhone Moment” 41:41 - Who Can Copy This Model And Why Size Matters 44:46 - Using Stretch To Build Products Outside The US 46:28 - A UK Bank Product Backed By Stretch 47:48 - Why Stretch Is Attractive For Businesses Holding Cash 50:07 - Bitcoin For Corporations Is Now Stretch 52:53 - Where To Learn More And What’s Coming Next

Chaitanya Jain

96,491 次观看 • 5 个月前

I sat down with John Pompliano to discuss bitcoin, why the price is going down, what’s going on with the Federal Reserve, Lisa Cook and the pressure from the White House, prediction for the next 10 years of the US economy, and will Powell cut interest rates? Enjoy! YouTube: Spotify: Apple: TIMESTAMPS: 0:00 - Intro 0:23 - Why is bitcoin dropping? 4:34 - Bitcoin vs money supply 12:12 - Where does bitcoin go from here? 21:31 - Why bitcoin is now a consensus trade 25:44 - Early bitcoin stories and ancient coins 34:44 - Feedback from Jerome Powell and Jackson Hole 41:00 - Lisa Cook situation and where we go from here

I sat down with John Pompliano to discuss bitcoin, why the price is going down, what’s going on with the Federal Reserve, Lisa Cook and the pressure from the White House, prediction for the next 10 years of the US economy, and will Powell cut interest rates? Enjoy! YouTube: Spotify: Apple: TIMESTAMPS: 0:00 - Intro 0:23 - Why is bitcoin dropping? 4:34 - Bitcoin vs money supply 12:12 - Where does bitcoin go from here? 21:31 - Why bitcoin is now a consensus trade 25:44 - Early bitcoin stories and ancient coins 34:44 - Feedback from Jerome Powell and Jackson Hole 41:00 - Lisa Cook situation and where we go from here

Anthony Pompliano 🌪

35,033 次观看 • 11 个月前

Fr. Rev. Robert Sirico on Why Catholic Teaching Rejects Socialism, Marxism and Antisemitism (00:00) Fr. Robert Sirico’s unlikely journey (12:53) His gangster brother, The Sopranos, and a family unlike any other (18:02) The Holocaust and moral conscience (23:44) Chaos on the Left—and now on the Right (27:39) Catholicism, anti-Semitism, and the Jewish roots of Christianity (33:34) Loyalty, truth, and when friends go wrong (38:13) Why economics matters more than politics (40:30) What the parables reveal about socialism (56:23) Is it wrong to like nice things? (01:00:24) Should religious leaders stay out of politics? (01:07:04) Acton Institute and the moral case for a free society (01:10:20) Why classical education is growing (01:14:17) Catholicism “on one foot” (01:17:18) Truth, and the antidote to cultural chaos

Fr. Rev. Robert Sirico on Why Catholic Teaching Rejects Socialism, Marxism and Antisemitism (00:00) Fr. Robert Sirico’s unlikely journey (12:53) His gangster brother, The Sopranos, and a family unlike any other (18:02) The Holocaust and moral conscience (23:44) Chaos on the Left—and now on the Right (27:39) Catholicism, anti-Semitism, and the Jewish roots of Christianity (33:34) Loyalty, truth, and when friends go wrong (38:13) Why economics matters more than politics (40:30) What the parables reveal about socialism (56:23) Is it wrong to like nice things? (01:00:24) Should religious leaders stay out of politics? (01:07:04) Acton Institute and the moral case for a free society (01:10:20) Why classical education is growing (01:14:17) Catholicism “on one foot” (01:17:18) Truth, and the antidote to cultural chaos

Marissa Streit

52,328 次观看 • 5 个月前

well seeing as i missed Chairman Birb Bernanke's peptide soiree in NYC i figured i would at least follow it up with a niche podcast version with Max Marchione we covered: - retatrutide - elli lilly - enhanced games 00:00 - Me rambling by myself in my room 02:58 - Max Marchione intro 04:44 - retatrutide phase 3 trial 06:00 - Crémieux reaction 10:20 - Elli Lilly $1T in market cap 11:17 - MTS reaction 13:56 - Elli Lilly BPC-157? 15:40 - Enhanced Games recap (my words) 20:18 - Max’s thoughts on the Enhanced Games 24:11 - Is it too early to be selling peptides online? 27:15 - Superpower peptide update 29:35 - Peptide sales and reclassification predictions 30:50 - We’re still early

well seeing as i missed Chairman Birb Bernanke's peptide soiree in NYC i figured i would at least follow it up with a niche podcast version with Max Marchione we covered: - retatrutide - elli lilly - enhanced games 00:00 - Me rambling by myself in my room 02:58 - Max Marchione intro 04:44 - retatrutide phase 3 trial 06:00 - Crémieux reaction 10:20 - Elli Lilly $1T in market cap 11:17 - MTS reaction 13:56 - Elli Lilly BPC-157? 15:40 - Enhanced Games recap (my words) 20:18 - Max’s thoughts on the Enhanced Games 24:11 - Is it too early to be selling peptides online? 27:15 - Superpower peptide update 29:35 - Peptide sales and reclassification predictions 30:50 - We’re still early

atlas

37,704 次观看 • 2 个月前